Neurotrophins are a group of proteins that play a critical role in the health and function of our nervous system. They are ...

Peptide Therapeutics MarketThe global peptide therapeutics market is on a strong growth trajectory, with sales projected to ...

The global leukemia therapeutics treatment market has seen considerable growth, progressing from USD 14,504.8 million in 2022 to USD 15,246.7 million in 2023. With a projected compound annual growth ...

The veterinary auto-immune therapeutics market is projected to grow at a 5.3% CAGR, reaching $71.7 billion by 2033.

( MENAFN - GlobeNewsWire - Nasdaq) Germany's peptide therapeutics market is set to grow at a 3.3% CAGR from 2024 to 2034, driven by strong healthcare systems, favorable policies, and the rise of ...

STAMFORD, Conn. and HOUSTON, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) and Tvardi Therapeutics, Inc. (“Tvardi”), a privately held ...

(RTTNews) - Cara Therapeutics, Inc. (CARA), Wednesday announced that the company has entered into a merger agreement with Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--SiteOne Therapeutics, Inc., a biopharmaceutical company developing selective ion channel modulators for the treatment of pain, cough, and other ...

Century Therapeutics entered the partnership three years ago. Bristol Myers Squibb is ending its drug development partnership with Philadelphia cell therapy company Century Therapeutics ...

Stevie Wonder pictured last year during MusiCares Persons of the Year Honoring Berry Gordy. Last night in Los Angeles, Wonder asked the audience to rise for Gordy, still up for a night out at age 95.

Stevie sat down with Stephanie Ruhle to talk about his work and the new film. Sami Sage, Pablo Torre, and Luke Russert join them for The Nightcap on The 11th Hour.

Shares of CRISPR Therapeutics have struggled amid less-than-stellar sales of its Casgevy therapy. The company's gene-editing biotechnology holds much promise but still faces significant uncertainties.